ENTITY
Livzon Pharmaceutical Group

Livzon Pharmaceutical Group (1513 HK)

108
Analysis
Health Care • China
Livzon Pharmaceutical Group is a comprehensive pharmaceutical company engaged in the research, development, production, and sales of various pharmaceutical products. Its portfolio includes chemical drugs, biological drugs, traditional Chinese medicine, and in vitro diagnostic reagents, covering therapeutic areas such as digestion, cardiovascular, reproductive endocrinology, and mental/nervous systems. The company was founded in January 1985 and is headquartered in Zhuhai City, Guangdong Province, China.
more
•14 Oct 2020 16:08

Simcere Pharmaceutical IPO: Valuation Insights

We think that an attractive PEG valuation and solid cornerstone support makes Simcere tempting at the proposed pricing range

Logo
566 Views
Share
•10 Oct 2020 17:29

Simcere Pharmaceutical IPO Initiation: A Rough Patch?

The timing of the IPO is not ideal as Simcere is coming off a weak 1H20. However, Simcere is putting in place the right measures to ensure that the...

Logo
513 Views
Share
•24 Feb 2020 21:13

Full Circulation Of H Shares: Signs Of Life

On the 29 December 2017, the China Securities Regulatory Commission's ("CSRC") announced it would launch the H-share Full Circulation Pilot...

Logo
636 Views
Share
bullish•China Tower
•19 Nov 2019 18:28

CSRC Green Lights Full Circulation Of H Shares

Back in June last year, I flagged (Legend's Conversion of Domestic Shares) 850mn shares entering Legend Holdings Corp H (3396 HK)'s share registry...

Logo
966 Views
Share
bullish•Quantitative Analysis
•23 Sep 2019 10:59

HK Connect Ideas: First Weekly Outflows in 19 Weeks, SMIC, Auto Sector (2019-09-20)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
781 Views
Share
x